Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Nasopharyngeal Carcinoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Head and Neck Cancer (562
)
Thyroid Gland Carcinoma (359
)
Squamous Cell Carcinoma of Head and Neck (292
)
Salivary Gland Cancer (57
)
Oral Cancer (53
)
Oropharyngeal Cancer (23
)
Maxillary Sinus Carcinoma (6
)
Tongue Carcinoma (5
)
Head and Neck Cancer (562
)
Thyroid Gland Carcinoma (359
)
Squamous Cell Carcinoma of Head and Neck (292
)
Salivary Gland Cancer (57
)
Oral Cancer (53
)
Oropharyngeal Cancer (23
)
Maxillary Sinus Carcinoma (6
)
Tongue Carcinoma (5
)
›
Associations
(59)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
toripalimab-tpzi
Sensitive: A1 - Approval
toripalimab-tpzi
Sensitive
:
A1
toripalimab-tpzi
Sensitive: A1 - Approval
toripalimab-tpzi
Sensitive
:
A1
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
Sensitive: A2 - Guideline
Sensitive
:
A2
Sensitive: A2 - Guideline
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
oxaliplatin
Sensitive: A2 - Guideline
oxaliplatin
Sensitive
:
A2
oxaliplatin
Sensitive: A2 - Guideline
oxaliplatin
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
doxorubicin hydrochloride
Sensitive: A2 - Guideline
doxorubicin hydrochloride
Sensitive
:
A2
doxorubicin hydrochloride
Sensitive: A2 - Guideline
doxorubicin hydrochloride
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
ifosfamide
Sensitive: A2 - Guideline
ifosfamide
Sensitive
:
A2
ifosfamide
Sensitive: A2 - Guideline
ifosfamide
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
vinorelbine tartrate
Sensitive: A2 - Guideline
vinorelbine tartrate
Sensitive
:
A2
vinorelbine tartrate
Sensitive: A2 - Guideline
vinorelbine tartrate
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
irinotecan
Sensitive: A2 - Guideline
irinotecan
Sensitive
:
A2
irinotecan
Sensitive: A2 - Guideline
irinotecan
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
capecitabine
Sensitive: A2 - Guideline
capecitabine
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
5-fluorouracil
Sensitive: A2 - Guideline
5-fluorouracil
Sensitive
:
A2
5-fluorouracil
Sensitive: A2 - Guideline
5-fluorouracil
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.